$18.16 - DNLI | Denali Therapeutics Inc. Common Stock

Denali Therapeutics Inc. Common Stock (DNLI)

Denali Therapeutics Inc. Common Stock

XNAS:DNLI

18.16

-6.73%

Ask

$21.71 - 100.00

Bid

$18.16 - 2.00

Low

$18

High

$19.13

Open

$19.1

Prev Close

$19.47

52W High

26.18

52W Low

10.57

Volume

1539007

Avg Vol (3m)

1334635

Float

130462742.11

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2836

Sector: Health Technology

Industry: Biotechnology

Date Listed: 12/08/2017

Primary Exchange: XNAS

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Phone: (650) 866-8547

Address: 161 Oyster Point Blvd.

City: South San Francisco

State: CA

Postal Code: 94080

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

517

P/E (TTM)

-6.240000

P/B (TTM)

2.874900

EPS

-0.74

Round Lot

100

Composit FIGI

BBG008P7F869

Share Class FIGI

BBG008P7F878

Share Class Shares Outstanding

146.21M

Weighted Shares Outstanding

146.66M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion